semaglutide cardiovascular outcomes news 2025 october currently not cost-effective for heart patients without diabetes, study finds Semaglutide 2.4 mg Clinical Outcomes

The free radical theory of aging postulates that accumulated damage from reactive oxygen species (ROS) over time contributes heavily to the functional decline of cells and tissues

Personalized Approach: Genetic Testing and Peptide Optimization The PlexusDx Precision Peptide Genetic Test analyzes GIPR, FTO (rs9939609), and MC4R (rs17782313) variants that relate to GLP-1 and related signaling pathways

[Abstract]2024 Feb 26;59(4):517-528.e3

A landmark study exploring the cardiovascular safety and benefits of Semaglutide in a large cohort of patients with type 2 diabetes

We endorse vitamin C by iS Clinical, Synergie, Obaji, Zo, & Skinceuticals